Pharma Stocks
-
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) — NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that…
Read More » -
Five things for pharma marketers to know for Monday, October 20, 2025
The stock prices for Novo Nordisk and Eli Lilly dipped after President Donald Trump vowed to lower the price of…
Read More » -
Investment Advisor Goes All-In on Big Pharma Stock to the Tune of $1.07 Billion, According to Recent Filing
Key Points Increased position by 259,392 shares in Q3 2025; estimated $193.03 million trade based on the average price during…
Read More » -
Waters Surges 10% After New Pharma Collaboration Has the Market Priced in Future Growth?
Trying to decide what to do with Waters stock? You’re not alone. Whether you’ve already got a stake or are…
Read More » -
Recursion (RXRX) Gains After Acquiring Exscientia and Expanding AI Pharma Partnerships Has the Risk Profile Shifted?
In recent weeks, Recursion Pharmaceuticals has accelerated its AI-driven drug discovery platform through the acquisition of Exscientia and expanded major…
Read More » -
Has West Pharma’s Recent Share Rebound Outpaced Its Fundamentals in 2025?
Are you wondering whether it’s the right time to add West Pharmaceutical Services to your portfolio, hold out for a…
Read More » -
Is Now the Right Moment for West Pharma After Its Latest Earnings and 5% Monthly Gain?
If you are thinking about what to do with West Pharmaceutical Services stock, you are not alone. The recent moves…
Read More » -
BridgeBio Pharma (BBIO): Evaluating Whether Its Recent Surge Leaves Shares Undervalued
BridgeBio Pharma (BBIO) stock has been steadily rising over the past month, gaining 7% and climbing 18% over the past…
Read More » -
aTyr Pharma Independent Director Acquires 91% More Stock
aTyr Pharma, Inc. (NASDAQ:ATYR) shareholders (or potential shareholders) will be happy to see that the Independent Director, Paul Schimmel, recently…
Read More » -
We’re Not Worried About LTR Pharma’s (ASX:LTP) Cash Burn
There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com…
Read More »